70874-20-3

Upstream product

• 70897-16-4 (R)-(+)-3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-carboxylic acid methyl ester 
• 53101-49-8 (R)-trolox 
• 77286-98-7 (R)-4-(2,5-Dihydroxy-3,4,6-trimethyl-phenyl)-2-hydroxy-2-methyl-butyric acid 
• 77257-11-5 (R)-2-Hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-butyric acid 

Downstream Products

• 70874-21-4 (R)-(-)-methyl 2-methyl-2-[(methylsulfonyl)oxy]-4-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)butanoate 
• 70874-21-4 methyl (R)-(-)-2-methyl-2-<(methylsulfonyl)oxy>-4-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)butanoate 
• 77270-00-9 (R)-4-(2,5-Dihydroxy-3,4,6-trimethyl-phenyl)-2-methanesulfonyloxy-2-methyl-butyric acid methyl ester 
• 77286-99-8 (R)-4-(2,5-Dihydroxy-3,4,6-trimethyl-phenyl)-2-hydroxy-2-methyl-butyric acid methyl ester 

Relevant academic research and scientific papers

Chemical compound containing a superoxide scavenger and an organic nitrate or nitrite moiety

Compounds for use in the treatment of heart disease include a superoxide scavenger and an organic nitrate or nitrite moiety. The compounds can be represented by the formula (A)n(B)m, in which A is a superoxide scavenger, B is an organic nitrate or organic

3,6-Dioxo-1,4-cyclohexadien-1-yl-butandate esters

A process for inversion of the stereo configuration of (R)-(+)-3,4-dihydro-6-hydroxy-2,5,7,8-tetraalkyl-2H-1-benzopyran-2-carboxylic acid and derivatives thereof to form the corresponding S-(-) acid and intermediates in this process.